Is it worth it

Is Under-Eye Filler Worth It?

MirrorMD Guides · Published September 18, 2026

The short answer: under-eye filler can produce excellent results for the right patient with the right injector, but the risk-to-reward math is very different from more forgiving areas like the cheeks or the lips. It is one of the highest-risk areas in the face, and the mistakes are more visible and last longer than mistakes in other areas.

This guide walks through what the published complication data shows, who is a good candidate, and how to tell whether the injector across from you is qualified to work in this region. Built by a physician with over 20 years of experience in facial cosmetic surgery.

Why the tear trough is different

The tear-trough region sits on top of critical vascular anatomy. A comprehensive review of periocular filler complications published in the peer-reviewed literature identifies it as one of the highest-risk zones for vascular injury in the face (PMC7583139, Complications after cosmetic periocular filler: prevention and management).

The specific anatomic concern: the infraorbital artery and nerve emerge through the infraorbital foramen approximately 3 cm lateral to midline, just below the orbital rim. Filler injected into the wrong tissue plane in this area can compress or embolize this artery. In the worst documented cases, vascular occlusion in the periocular region has caused vision loss.

Vision loss from filler is rare but not zero. The published literature specifically flags the glabella and tear-trough regions as the areas where this catastrophic complication is most likely.

The tear trough also has the thinnest facial skin, minimal subcutaneous fat, and a distinctive fat-compartment anatomy that makes filler behavior harder to predict than in the cheek or the chin.

The complication data

Beyond vascular injury, the tear trough has a specific set of complications documented in the review literature (PMC7583139):

Tyndall effect. Blue-grey discoloration visible through the skin when filler is placed too superficially. The mechanism is scattering of blue light through small particles in suspension. It happens more in the tear trough than anywhere else because the skin is thinnest there. Once it appears, it does not fade on its own — dissolving is the standard fix.

Migration and lumps. Under-eye filler migrates. Because the tissue plane is thin and gravity plus lymphatic drainage act on the region continuously, product placed here can shift over months to years, producing lumps, ridges, or a persistent puffy appearance that patients often mistake for their original bags getting worse.

Chronic puffiness. Hyaluronic acid attracts water. In the loose tissue plane of the tear trough, this can produce a persistent low-grade swelling that lasts as long as the filler is present. Patients report looking "always tired" or "always puffy" and often initially blame poor sleep before recognizing the filler is the cause.

Prolonged bruising. The vascular density of the region means bruising in the tear trough tends to be more visible and lasts longer than in other injection sites.

Chronic edema. Some patients develop persistent inflammation around under-eye filler that does not resolve with standard treatment. In these cases dissolving is often the only reliable resolution.

When under-eye filler is genuinely worth it

The published guidance and expert consensus converges on a specific candidate profile. Under-eye filler is a strong option when:

1. The problem is genuine anatomic hollowing — a true tear-trough depression that produces shadowing at the medial lower lid. Not dark pigmentation. Not lower-lid fat bags. Not fine wrinkles. A hollow.
2. The surrounding tissue is otherwise healthy — good skin quality, no pre-existing chronic under-eye edema, no history of lower-lid surgery, no significant fat bags that the filler would need to blend around.
3. The injector has documented tear-trough experience — not just filler experience, tear-trough-specifically experience, with before-and-after photos of their own patients they can show you.
4. The patient understands the dissolving option and has a written cost estimate for it in advance.

If all four are true, the risk-to-reward can favor filler. If any one is missing, the risk-to-reward often does not.

Who should skip under-eye filler

• Your under-eye concern is dark pigmentation. Filler does not treat pigment. It can occasionally make dark circles worse by adding volume that changes the light reflection. Topical brightening (vitamin C, azelaic acid, prescription hydroquinone under supervision) is the correct tool.
• Your under-eye concern is skin texture. Crepe-y skin, fine wrinkles, and loss of firmness are not filler problems. They are skin-quality problems addressed by resurfacing procedures (fractional laser, RF microneedling), retinoids, and time.
• You have significant lower-lid fat bags. Filler placed to "hide" the bags typically produces a worse contour, because it compounds the volume problem the bags represent. A surgical lower blepharoplasty is the correct intervention. Adding filler to a bagged eye is a common cause of the "chipmunk cheek" outcome that patients later regret.
• You have a history of poor filler experiences elsewhere. Patients who have had chronic swelling or migration with filler in other areas often experience worse versions of both in the tear trough.
• You cannot get a written before-cost for dissolving. If the clinic will not price the safety net in advance, the safety net is not there.

How to evaluate the injector

The tear trough is not a place to test a new injector. Specifically ask:

1. How many tear-trough treatments do you personally perform per month? A busy tear-trough injector does dozens per month. Once or twice a month is not high volume.
2. May I see before-and-after photos of your own tear-trough patients? Not stock photos. Not manufacturer photos. The injector's own portfolio, taken in the same room you are sitting in.
3. What is your protocol if the patient develops the Tyndall effect or migration? A qualified answer includes hyaluronidase in-house, a specific dosing protocol, and a described follow-up cadence. A hesitant answer means the injector is not planning for complications.
4. What technique do you use — cannula or needle? Both can be safe in trained hands, but the injector should have a considered answer and a specific rationale for their choice.
5. How much are we starting with? The right answer for most first-time tear-trough patients is 0.5 to 1 syringe total, not 2. If the quote is 2+ syringes for a first appointment, that is often an overtreatment plan.

Alternatives to consider first

• Sleep, hydration, and salt reduction. Under-eye puffiness has a large lifestyle component. Two weeks of consistent 8-hour sleep and reduced sodium change how many patients look in the mirror.
• Topical retinoids and brightening agents. Address pigment and texture components without adding volume risk.
• Cold-compress and lymphatic drainage. For chronic puffy under-eyes, sometimes the answer is lymphatic dysfunction, not volume loss.
• Surgical lower blepharoplasty with fat repositioning. For true tear-trough hollowing in a patient with lower-lid bag anatomy, this is often the permanent correct answer that filler cannot replicate.
• Doing nothing. The under-eye area is one of the most photographed and least remarkable features on most faces. A concern amplified by phone-camera selfies is often not visible in ordinary life.

The rule that survives every consult

The tear trough is the highest-risk-per-syringe area on the face. When a patient is a genuine anatomic candidate and the injector has real tear-trough experience, the results can be excellent. When either of those is missing, the same syringe of the same product can produce a complication that takes years to fully resolve. Ask about the injector's specific tear-trough experience before you ask about price.

This article is general education, not medical advice. It does not replace an in-person consultation with a licensed clinician.